Cyclooxigenase-2 expression in primary metastatic and non metastatic canine mammarian carcinomas

dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Federal do Paraná (UFPR)
dc.contributorUniv Estadual Norte Parana
dc.date.accessioned2014-12-03T13:07:05Z
dc.date.available2014-12-03T13:07:05Z
dc.date.created2014-12-03T13:07:05Z
dc.date.issued2013-01-01
dc.identifierArchivos De Medicina Veterinaria. Valdivia: Univ Austral Chile, Fac Ciencias Veterinarias, v. 45, n. 3, p. 311-316, 2013.
dc.identifier0301-732X
dc.identifierhttp://hdl.handle.net/11449/111230
dc.identifier10.4067/S0301-732X2013000300012
dc.identifierWOS:000330203700011
dc.identifierWOS000330203700011.pdf
dc.description.abstractThe aim of this study was to detect the expression of ciclooxigenase-2 (COX-2) in metastatic primary carcinoma and non metastatic carcinoma, taking into consideration the relation between COX-2 and the progression of cancer. Evaluation of the COX-2 expression was achieved by immunohistochemistry analysis, using the primary polyclonal antibody anti-PGHS-2, clone PG 27, (Oxford Biomedical Research). The number of marked cells by the COX-2 antibody was higher (P < 0.001) in the metastatic primary carcinoma (81.25%) than non-metastatic (60.3%). There was a positive correlation between the number of labeled cells.
dc.languagespa
dc.publisherUniv Austral Chile, Fac Ciencias Veterinarias
dc.relationArchivos de Medicina Veterinária
dc.relation0.236
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjectCancer
dc.subjectMammary neoplasm
dc.subjectciclooxigenase-2
dc.subjectDog
dc.titleCyclooxigenase-2 expression in primary metastatic and non metastatic canine mammarian carcinomas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución